# Premier Pharma 1 LP — Form D

Premier Pharma 1 LP of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2016-12-07. Industry: Pooled Investment Fund.

## Offering

- Filed: 2016-12-07
- Form: D
- Accession: 0000950103-16-018563
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Minimum investment: $500K
- Security types: fund interests
- SEC file number: 021-275824

## Issuer

- Name: Premier Pharma 1 LP
- CIK: 0001691681
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 522 FIFTH AVENUE, 13TH FLOOR, NEW YORK, NY, 10036
- Phone: 212-296-6000

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Jeremy Beal | Director | New York, NY |
| James Bruno | Director | New York, NY |
| Michael Korn | Director | New York, NY |
| - Morgan Stanley Strategies II LLC | Executive Officer | NEW YORK, NY |

## More

- [CIK 1691681 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1691681&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0000950103-16-018563.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.